Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.
about
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Multi-center phase II trial of ...... ous stem cell transplantation.
@en
Multi-center phase II trial of ...... ous stem cell transplantation.
@nl
type
label
Multi-center phase II trial of ...... ous stem cell transplantation.
@en
Multi-center phase II trial of ...... ous stem cell transplantation.
@nl
prefLabel
Multi-center phase II trial of ...... ous stem cell transplantation.
@en
Multi-center phase II trial of ...... ous stem cell transplantation.
@nl
P2093
P2860
P1476
Multi-center phase II trial of ...... gous stem cell transplantation
@en
P2093
Alex F Herrera
Auayporn P Nademanee
Jessica Alluin
Ji-Lian Cai
John J Rossi
Joycelynne M Palmer
Larry W Kwak
Leona A Holmberg
Leslie L Popplewell
P2860
P2888
P356
10.1186/S13045-018-0631-3
P577
2018-06-28T00:00:00Z
P6179
1105169705